Terns Pharmaceuticals Inc (TERN)
6.15
-0.10
(-1.60%)
USD |
NASDAQ |
May 21, 16:00
6.15
0.00 (0.00%)
After-Hours: 16:50
Terns Pharmaceuticals Free Cash Flow: -75.89M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -75.89M |
| December 31, 2023 | -67.44M |
| September 30, 2023 | -59.33M |
| June 30, 2023 | -52.05M |
| March 31, 2023 | -50.22M |
| December 31, 2022 | -49.38M |
| September 30, 2022 | -49.01M |
| Date | Value |
|---|---|
| June 30, 2022 | -43.74M |
| March 31, 2022 | -41.37M |
| December 31, 2021 | -42.17M |
| September 30, 2021 | -38.73M |
| June 30, 2021 | -36.89M |
| March 31, 2021 | -37.02M |
| December 31, 2020 | -30.39M |
Free Cash Flow Range, Past 5 Years
-75.89M
Minimum
Mar 2024
-30.39M
Maximum
Dec 2020
-48.12M
Average
-46.37M
Median
Free Cash Flow Benchmarks
| Viking Therapeutics Inc | -54.87M |
| Eli Lilly and Co | -3.896B |
| Pfizer Inc | 5.106B |
| Amgen Inc | 7.098B |
| Madrigal Pharmaceuticals Inc | -391.12M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -22.80M |
| Cash from Investing (Quarterly) | 7.997M |
| Free Cash Flow Per Share (Quarterly) | -0.3068 |
| Free Cash Flow Yield | -17.04% |